ONCOSEC MEDICAL INC Share Price Today: Live Updates & Key Insights

ONCOSEC MEDICAL INC share price today is $null, up null%. The stock opened at $null against the previous close of $null, with an intraday high of $null and low of $null.

ONCOSEC MEDICAL INC Share Price Chart

ONCOSEC MEDICAL INC

us-stock
To Invest in {{usstockname}}
us-stock

ONCOSEC MEDICAL INC Share Price Performance

$null null(null%) null at 23 Mar 2026 02:36 PM Biotechnology
Lowest Today 0.00
Highest Today 0.00
Today’s Open 0.00
Prev. Close 0.00
52 Week High 0.00
52 Week Low 0.00
Day’s Range: Low null High null
52-Week Range: Low 0.00 High 0.00
1 day return -
1 Week return -
1 month return -
3 month return -
6 month return -
1 year return -
3 year return -
5 year return -
10 year return -

ONCOSEC MEDICAL INC Institutional Holdings

ONCOSEC MEDICAL INC Market Status

ONCOSEC MEDICAL INC Fundamentals

Market Cap 0.00 M

PB Ratio 0.8302

PE Ratio 0.0

Enterprise Value 0.00 M

Total Assets 21.88 M

Volume null

ONCOSEC MEDICAL INC Company Financials

About ONCOSEC MEDICAL INC & investment objective

Company Information OncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company's product pipeline includes KEYNOTE-695, which is in Phase 2 trial for the treatment of advanced melanoma; TAVO + SARS-CoV-2 spike glycoprotein, which is in Phase 1 clinical trial for the treatment of COVID-19; and TAVO + epacadostat + pembrolizumab, which is in Phase 1 clinical trial for the treatment of squamous cell carcinoma head and neck cancer. Its pipeline also comprises TAVO +nivolumab, which is in Phase 2 clinical trial for the treatment of breast cancer; TAVO + CXCL9 for the treatment of solid tumors; and OMS-100 and OMS-102, which are in Phase 2 clinical trial for the treatment of metastatic melanoma. OncoSec Medical Incorporated has clinical trial collaborations with Merck & Co., Inc. and its subsidiary in connection with the KEYNOTE-695 and KEYNOTE-890; and a research collaboration with Duke University's Center for Applied Therapeutics to evaluate TAVO in combination or sequenced with a HER2-plasmid vaccine. The company was formerly known as NetVentory Solutions Inc. and changed its name to OncoSec Medical Incorporated in March 2011. OncoSec Medical Incorporated was incorporated in 2008 and is headquartered in Pennington, New Jersey. On June 14, 2023, OncoSec Medical Incorporated filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of New Jersey.

Organisation Biotechnology

Employees 40

Industry Biotechnology

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

ONCOSEC MEDICAL INC FAQs

What is the share price of ONCOSEC MEDICAL INC today?

The current share price of ONCOSEC MEDICAL INC is $null.

Can I buy ONCOSEC MEDICAL INC shares in India?

Yes, Indian investors can buy ONCOSEC MEDICAL INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy ONCOSEC MEDICAL INC shares in India?

You can easily invest in ONCOSEC MEDICAL INC shares from India by:

Can I buy fractional shares of ONCOSEC MEDICAL INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of ONCOSEC MEDICAL INC?

ONCOSEC MEDICAL INC has a market cap of $0.00 M.

In which sector does ONCOSEC MEDICAL INC belong?

ONCOSEC MEDICAL INC operates in the Biotechnology sector.

What documents are required to invest in ONCOSEC MEDICAL INC stocks?

To invest, you typically need:

What is the PE and PB ratio of ONCOSEC MEDICAL INC?

The PE ratio of ONCOSEC MEDICAL INC is N/A and the PB ratio is 0.83.